(Q39593973)

13 September 2017

title

Epigenetic inactivation of PCDH10 in human prostate cancer cell lines (English)

1 reference

13 September 2017

1 reference

Zesong Li

1

1 reference

13 September 2017

Wenjie Li

2

1 reference

13 September 2017

Jun Xie

3

1 reference

13 September 2017

Yong Wang

4

1 reference

13 September 2017

Aifa Tang

5

1 reference

13 September 2017

Xianxin Li

6

1 reference

13 September 2017

Jiongxian Ye

7

1 reference

13 September 2017

Yaoting Gui

8

1 reference

13 September 2017

Zhiming Cai

9

1 reference

13 September 2017

publication date

1 July 2011

1 reference

Cell Biology International

13 September 2017

published in

1 reference

13 September 2017

volume

35

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

671-676

1 reference

Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Concepts of epigenetics in prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Altered DNA methylation: a secondary mechanism involved in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Epigenetic changes in prostate cancer: implication for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

MethPrimer: designing primers for methylation PCRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Identification and characterization of human PCDH10 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Identifying autism loci and genes by tracing recent shared ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Identification and characterization of three members of a novel subclass of protocadherins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Clustered protocadherin family

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100568

21 January 2018

Identifiers

DOI

10.1042/CBI20100568

1 reference

13 September 2017

1 reference